Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Nervous Tissue: Myelin

Nervous Tissue: Myelin

The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

Antiepileptic Drugs: GABAergic Pathway Potentiators

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...

Encephalitis ll: Pathophysiology

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

Action Potential

Action Potential

Neurons communicate by firing action potentials—the electrochemical signal that is propagated along the axon. The signal results in the release of neurotransmitters at axon terminals, thereby transmitting information to the nervous system. An action potential is a specific "all-or-none" change in membrane potential that results in a rapid spike in voltage.
Membrane potential in neurons
Neurons typically have a resting membrane potential of about -70 millivolts (mV). When they receive...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Nightmare disorder shows reduced slow oscillation-dominant spindle coupling in NREM sleep.

Npj biological timing and sleep·2026

Same author

Evolution of the frontal aslant tract and implications for primate vocalization and human speech.

Nature communications·2026

Same author

Machine learning to diagnose, classify and predict phenoconversion in isolated REM sleep behavior disorder.

Sleep medicine reviews·2026

Same author

A New Branch on a Deep-Rooted Tree.

Journal of sleep research·2026

Same author

Peripheral inflammation is associated with reduced influx of TSPO PET tracers into the brain: insights from a non-invasive mapping methodology.

Brain, behavior, and immunity·2026

Same author

Network-based disease fingerprinting with neuroinflammation PET imaging.

Journal of neuroinflammation·2026

Search research articles

Related Experiment Video

Updated: May 21, 2026

Preparation and Immunostaining of Myelinating Organotypic Cerebellar Slice Cultures

Preparation and Immunostaining of Myelinating Organotypic Cerebellar Slice Cultures

Published on: March 20, 2019

Neuroconnectivity and valproic acid: the myelin hypothesis.

Ivana Rosenzweig¹, Zoran Vukadinovic, Anthony J Turner

¹Academic Unit of Sleep and Department of Psychiatry, Royal Brompton Hospital, London, UK. i.rosenzweig@camprot.com

Neuroscience and Biobehavioral Reviews

|June 2, 2012

Summary

Valproic acid, a neuropsychiatric drug, may disrupt brain development by inhibiting myelination. Further research is needed to understand its long-term effects on neuroconnectivity and cognitive function.

More Related Videos

Coherent Anti-Stokes Raman Spectroscopy (CARS) Application for Imaging Myelination in Brain Slices

Coherent Anti-Stokes Raman Spectroscopy (CARS) Application for Imaging Myelination in Brain Slices

Published on: July 22, 2022

Related Experiment Videos

Last Updated: May 21, 2026

Preparation and Immunostaining of Myelinating Organotypic Cerebellar Slice Cultures

Preparation and Immunostaining of Myelinating Organotypic Cerebellar Slice Cultures

Published on: March 20, 2019

Coherent Anti-Stokes Raman Spectroscopy (CARS) Application for Imaging Myelination in Brain Slices

Coherent Anti-Stokes Raman Spectroscopy (CARS) Application for Imaging Myelination in Brain Slices

Published on: July 22, 2022

Area of Science:

Neuroscience
Neuropharmacology
Developmental Biology

Background:

Neuropsychiatric medications like valproic acid can alter the epigenome.
Valproic acid has been shown in animal models to inhibit myelination and impair remyelination.
Human brain myelination is a prolonged, heterochronous process extending into adulthood, influencing cognitive plasticity.

Purpose of the Study:

To investigate the potential impact of valproic acid on the human central nervous system's myelination process.
To explore how chronic valproic acid exposure may affect neuroconnectivity and developmental trajectories.
To highlight the need for further research into valproic acid's effects on adult brain development.

Main Methods:

Review of existing animal model data on valproic acid's effects on myelination.
Comparison of human and non-human primate myelination processes.
Discussion of the implications for patients with epilepsy and neuropsychiatric disorders.

Main Results:

Valproic acid inhibits postnatal myelination and reduces remyelination efficiency in animal models.
Human myelination is a complex, extended process distinct from animal models.
Chronic valproic acid exposure may significantly alter brain development and neuroconnectivity.

Conclusions:

Valproic acid's epigenetic activity poses a risk to the ongoing myelination process in the human brain.
The unique trajectory of human brain myelination may make it particularly vulnerable to drugs like valproic acid.
Novel in vivo MRI techniques are essential to study valproic acid's lifelong impact on myelination and brain function.